
Guangzhou University
Also known as: Chinese Traditional Medical Hospital of Guangdong Province | Department of Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine | Director of cancer center of Guangdong PPH | First affiliated hospital of guangzhou university of traditional Chinese medicine | Guangdong PPH | Guangdong Province Traditional Medical hospital | Guangdong Provincial Hospital of Chinese Medicine | Guangdong Provincial Hospital of Chinese Medicine, China | Guangzhou 8th hospitol | Guangzhou Fuda Cancer Hospital | Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences | Guangzhou mental Hospital Attached to Guangzhou Civil Affairs Bureau | Guangzhou University of Chinese Medecine | Guangzhou University of Traditional Chinese Medicine | the chief of the neurology department, Chinese Traditional Medical Hospital of Guangdong Province | the First Affiliated Hospital, Guangzhou University of Chinese Medicine | The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | the First Affiliated Hospital of Guangzhou MC | the first affiliated hospital of Guangzhou University of Chinese Medicine , Guangzhou | the first affiliated hospital of Guangzhou University of Chinese Medicine, Guangzhou | the First Affiliated Hospital of Guangzhou University of TCM | The First Affiliated Hospital of Guizhou University of TCM | The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2005Last known activity
Dec 1, 2025
Timeline
2000s
- Jun 1, 2000
Guangzhou University— Founded
Drugs by trial phase (93 distinct, 68 trials)
Phase 4 (23 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Anemia
- Angina Pectoris
- Angina, Stable
- Bipolar Disorder
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carotid Stenosis
- Cerebral Hemorrhage
- Cerebral Infarction
- Colonic Neoplasms
- Colorectal Neoplasms
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Death
- Dementia
- Dementia, Vascular
- Dengue
- Depression
- Depressive Disorder
- Diarrhea
- Disease
- Fever
- Heart Diseases
- Hemorrhage
- Hemorrhagic Fevers, Viral
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- HIV Infections
- Infarction
- Intracranial Arteriosclerosis
- Intracranial Embolism
- Intracranial Thrombosis
- Ischemia
- Kidney Neoplasms
- Liver Neoplasms
- Lung Neoplasms
- Menopause, Premature
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms, Second Primary
- Pancreatic Neoplasms
- Pericardial Effusion
- Pleural Effusion
- Pleural Effusion, Malignant
- Primary Ovarian Insufficiency
- Prostatic Neoplasms
- Sleep Initiation and Maintenance Disorders
- Stomach Neoplasms
- Stroke
- Syndrome
- Thalassemia
- Vaginal Diseases
- Vaginosis, Bacterial
Recent trials (50)
- NCT07231523CollaboratorPhase 3Dec 1, 2025
- NCT06356675Sponsor investigatorPhase 4Jul 1, 2024
- NCT06356675Lead sponsorPhase 4Jul 1, 2024
- NCT06255379Lead sponsorPhase 2May 6, 2024
- NCT06055179Reponsible party - principal investigatorN/AJan 15, 2024
- NCT06055179Lead sponsorN/AJan 15, 2024
- NCT06277674Sponsor investigatorPhase 2Nov 2, 2023
- NCT06277674Lead sponsorPhase 2Nov 2, 2023
- NCT06041477CollaboratorPhase 3Sep 30, 2023
- NCT05483595Lead sponsorPhase 3Aug 1, 2022
- NCT05439629OfficialPhase 3Jun 30, 2022
- NCT05439629Overall official - principal investigatorPhase 3Jun 30, 2022
- NCT05229809Overall official - principal investigatorPhase 4Mar 1, 2022
- NCT05160987CollaboratorN/AJan 1, 2022
- NCT05066620Reponsible party - principal investigatorPhase 3Oct 31, 2021
Details
- Founded
- Guangzhou, CN Jun 1, 2000
- Last known activity
- Dec 1, 2025